← Eichor
Condition: Gynecological Solid Tumors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gynecological Solid Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
Phase 1/Phase 2 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT05803018A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
Phase 2 · 4 location(s) · University of Oklahoma · NCT05512208Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecolo
Phase 2 · 3 location(s) · Emory University · NCT06492070Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C M
Phase 1/Phase 2 · 53 location(s) · Revolution Medicines, Inc. · NCT06128551A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors
NA · 1 location(s) · Obstetrics & Gynecology Hospital of Fudan University · NCT06904131A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Phase 1/Phase 2 · 81 location(s) · GlaxoSmithKline · NCT06796907Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Phase 1/Phase 2 · 21 location(s) · Revolution Medicines, Inc. · NCT05379985Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
Phase N/A · 7 location(s) · University Health Network, Toronto · NCT02906943
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.